Perimeter Medical Imaging AI (TSE:PINK)
:PINK
PINK Stock Chart & Stats
C$0.33
C$0.04(8.43%)
At close: 4:00 PM EST
C$0.33
C$0.04(8.43%)
Day’s Range― - ―
52-Week RangeC$0.17 - C$0.72
Previous CloseN/A
Volume7.08K
Average Volume (3M)55.39K
Market Cap
C$41.62M
Enterprise ValueC$22.63M
Total Cash (Recent Filing)C$2.35M
Total Debt (Recent Filing)C$101.75K
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Jun 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding126,112,560
10 Day Avg. Volume68,307
30 Day Avg. Volume55,392
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)2.60
Price to Sales (P/S)32.11
P/FCF Ratio-1.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$3.00Price Target Upside809.09% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.08
Revenue Forecast (FY)C$6.86M
Bulls Say, Bears Say
Bulls Say
Low LeverageVery low debt provides durable financial flexibility: it lowers solvency risk, preserves borrowing capacity for capital expenditures or clinical commercialization, and reduces fixed interest costs, enabling the company to prioritize R&D and go-to-market investments over urgent deleveraging.
Healthy Gross MarginA ~56.5% gross margin indicates strong unit economics from device sales and consumables. This margin tailwind supports long-term scalability: once fixed operating costs are absorbed, incremental sales can drive durable margin expansion and fund clinical support, service contracts, and product iteration.
Sustained Revenue GrowthConsistent revenue growth demonstrates progressing adoption of Perimeter's intraoperative imaging systems. Structural demand for improved surgical margin assessment and recurring consumable/service revenue create a multi-year growth runway, supporting scale benefits and longer-term commercialization prospects.
Bears Say
Negative ProfitabilityPersistent negative net and EBIT margins indicate the business is not yet operationally profitable. Without sustained operating leverage or cost reductions, continued losses can impair reinvestment capacity, delay returns to shareholders, and require recurring financing that dilutes long-term stakeholder value.
Negative Operating And Free Cash FlowNegative operating and free cash flow reflect ongoing cash burn from commercialization and operations. This structural cash shortfall increases reliance on external financing, which can dilute equity or constrain strategic initiatives, and raises execution risk if capital markets tighten over the next several quarters.
Negative Return On EquityA negative ROE despite low leverage signals that invested capital is not generating returns, pointing to structural profitability or pricing issues. Until ROE turns positive through margin improvement or higher asset turnover, capital allocation effectiveness and shareholder value creation remain impaired.
Perimeter Medical Imaging AI News
PINK FAQ
What was Perimeter Medical Imaging AI’s price range in the past 12 months?
Perimeter Medical Imaging AI lowest stock price was C$0.17 and its highest was C$0.72 in the past 12 months.
What is Perimeter Medical Imaging AI’s market cap?
Perimeter Medical Imaging AI’s market cap is C$41.62M.
When is Perimeter Medical Imaging AI’s upcoming earnings report date?
Perimeter Medical Imaging AI’s upcoming earnings report date is Jun 02, 2026 which is in 56 days.
How were Perimeter Medical Imaging AI’s earnings last quarter?
Perimeter Medical Imaging AI released its earnings results on Mar 31, 2026. The company reported -C$0.056 earnings per share for the quarter, missing the consensus estimate of -C$0.042 by -C$0.014.
Is Perimeter Medical Imaging AI overvalued?
According to Wall Street analysts Perimeter Medical Imaging AI’s price is currently Undervalued.
Does Perimeter Medical Imaging AI pay dividends?
Perimeter Medical Imaging AI does not currently pay dividends.
What is Perimeter Medical Imaging AI’s EPS estimate?
Perimeter Medical Imaging AI’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Perimeter Medical Imaging AI have?
Perimeter Medical Imaging AI has 126,112,560 shares outstanding.
What happened to Perimeter Medical Imaging AI’s price movement after its last earnings report?
Perimeter Medical Imaging AI reported an EPS of -C$0.056 in its last earnings report, missing expectations of -C$0.042. Following the earnings report the stock price went down -12.36%.
Which hedge fund is a major shareholder of Perimeter Medical Imaging AI?
Currently, no hedge funds are holding shares in TSE:PINK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Perimeter Medical Imaging AI Stock Smart Score
Company Description
Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc., a medical technology company, develops and commercializes advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. The company offers an optical coherence tomography (OCT) imaging system provides clinicians with cross-sectional of tissues down to 2 mm dept. This OCT imaging system consists of S-series OCT, B-series OCT, and OCT imaging console. It also offers ImgAssist, an artificial intelligence technology that enhances the efficiency of image review and be an additional powerful tool when combined with Perimeter OCT to aid physicians with real-time margin visualization and assessment to improve surgical outcomes for patients and reducing the likelihood of needing additional surgeries. In addition, the company offers proprietary image library and consumable specimen containers to hospitals and cancer surgery centers. Perimeter Medical Imaging AI, Inc. was founded in 2013 and is headquartered in Toronto, Canada.
PINK Stock 12 Month Forecast
Average Price Target
C$3.00
▲(809.09% Upside)
Technical Analysis
Aurora Spine
―
Imagin Medical
―
Theralase Technologies
―
VentriPoint Diagnostics
―
―
Options Prices
Currently, No data available
---